EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
Arbyn, Marc; de Sanjosé, Silvia; Saraiya, Mona; Sideri, Mario; Palefsky, Joel; Lacey, Charles; Gillison, Maura; Bruni, Laia; Ronco, Guglielmo; Wentzensen, Nicolas; Brotherton, Julia; Qiao, You-Lin; Denny, Lynnette; Bornstein, Jacob; Abramowitz, Laurent; Giuliano, Anna; Tommasino, Massimo; Monsonego, Joseph.
Int J Cancer
; 131(9): 1969-82, 2012 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-22623137
Declines in human papillomavirus infection observed in the vaccine era.
Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.
Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.
Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
Human papillomavirus epidemiology and vaccine recommendations: selected review of the recent literature.
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.
[Human papillomavirus infection and vaccination].
Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria.